Multiple immune cells and inflammatory pathways

Multiple immune cells and inflammatory pathways is a broad term describing the integrated network of various leukocyte populations and the signaling cascades that coordinate the body's response to injury or infection (StatPearls, 2023). This system involves diverse cell types, including T cells, B cells, neutrophils, and macrophages, which interact through complex pathways such as the NF-κB, JAK-STAT, and MAPK signaling modules (NCBI, 2022). These pathways regulate the production of pro-inflammatory cytokines and the recruitment of immune cells to sites of tissue damage (PubMed, 2021). Therapeutic intervention in these pathways typically involves broad-acting agents like corticosteroids or immunosuppressants that modulate multiple points of the inflammatory cascade to treat autoimmune and chronic inflammatory diseases (PubChem, 2024). Because this term encompasses a wide array of distinct biological entities and processes rather than a single protein, it is considered a systemic description of drug action rather than a discrete therapeutic target. Consequently, drugs targeting these pathways often have pleiotropic effects, impacting various aspects of the innate and adaptive immune systems simultaneously (NIH, 2023). Monitoring the efficacy of such treatments often requires broad biomarkers of systemic inflammation, such as C-reactive protein or cytokine profiles (Mayo Clinic, 2023).

Other names

Immune systemInflammatory cascadeSystemic inflammation

Broad modulation of immune cell activation, recruitment, and cytokine production through the inhibition of multiple intracellular signaling pathways and gene transcription (StatPearls, 2023).